Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
25044 | 244 | 31.8 | 78% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1233 | 8561 | DEOXYCYTIDINE KINASE//PURINE NUCLEOSIDE PHOSPHORYLASE//NUCLEOSIDE TRANSPORT |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CLOFARABINE | Author keyword | 55 | 52% | 31% | 75 |
2 | CANC THER EUT IMMUNOL | Address | 18 | 89% | 3% | 8 |
3 | NELARABINE | Author keyword | 16 | 60% | 7% | 18 |
4 | ARA G | Author keyword | 15 | 88% | 3% | 7 |
5 | CLOFARABINE TRIPHOSPHATE | Author keyword | 6 | 100% | 2% | 4 |
6 | 9 BETA D ARABINOFURANOSYLGUANINE | Author keyword | 5 | 60% | 2% | 6 |
7 | ARA GTP | Author keyword | 4 | 75% | 1% | 3 |
8 | ARABINOSYLGUANINE | Author keyword | 4 | 75% | 1% | 3 |
9 | 4 THIO ARA C | Author keyword | 3 | 100% | 1% | 3 |
10 | THIARABINE | Author keyword | 3 | 100% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CLOFARABINE | 55 | 52% | 31% | 75 | Search CLOFARABINE | Search CLOFARABINE |
2 | NELARABINE | 16 | 60% | 7% | 18 | Search NELARABINE | Search NELARABINE |
3 | ARA G | 15 | 88% | 3% | 7 | Search ARA+G | Search ARA+G |
4 | CLOFARABINE TRIPHOSPHATE | 6 | 100% | 2% | 4 | Search CLOFARABINE+TRIPHOSPHATE | Search CLOFARABINE+TRIPHOSPHATE |
5 | 9 BETA D ARABINOFURANOSYLGUANINE | 5 | 60% | 2% | 6 | Search 9+BETA+D+ARABINOFURANOSYLGUANINE | Search 9+BETA+D+ARABINOFURANOSYLGUANINE |
6 | ARA GTP | 4 | 75% | 1% | 3 | Search ARA+GTP | Search ARA+GTP |
7 | ARABINOSYLGUANINE | 4 | 75% | 1% | 3 | Search ARABINOSYLGUANINE | Search ARABINOSYLGUANINE |
8 | 4 THIO ARA C | 3 | 100% | 1% | 3 | Search 4++THIO+ARA+C | Search 4++THIO+ARA+C |
9 | THIARABINE | 3 | 100% | 1% | 3 | Search THIARABINE | Search THIARABINE |
10 | FORODESINE | 2 | 31% | 2% | 5 | Search FORODESINE | Search FORODESINE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 2 CHLORO 9 2 DEOXY 2 FLUORO BETA D ARABINOFURANOSYLADENINE | 55 | 78% | 15% | 36 |
2 | 9 BETA D ARABINOFURANOSYLGUANINE | 19 | 71% | 6% | 15 |
3 | ARABINOSYLGUANINE | 18 | 89% | 3% | 8 |
4 | ARABINOSYL GUANINE | 17 | 70% | 6% | 14 |
5 | 4 THIO BETA D ARABINOFURANOSYLCYTOSINE 4 THIO ARA C | 15 | 82% | 4% | 9 |
6 | REFRACTORY ACUTE LEUKEMIAS | 10 | 58% | 5% | 11 |
7 | FLUDARABINE TRIPHOSPHATE | 6 | 71% | 2% | 5 |
8 | ARABINONUCLEOSIDE | 4 | 75% | 1% | 3 |
9 | 506U78 | 4 | 56% | 2% | 5 |
10 | REFRACTORY HEMATOLOGIC MALIGNANCIES | 4 | 18% | 7% | 18 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Clofarabine in pediatric acute leukemia: Current findings and issues | 2012 | 10 | 29 | 83% |
Clofarabine in leukemia | 2010 | 14 | 25 | 68% |
Discovery and development of clofarabine: a nucleoside analogue for treating cancer | 2006 | 113 | 43 | 53% |
The role of clofarabine in acute myeloid leukemia | 2013 | 12 | 40 | 45% |
Clofarabine: Past, present, and future | 2007 | 41 | 24 | 71% |
Enzymology of Purine and Pyrimidine Antimetabolites Used in the Treatment of Cancer | 2009 | 96 | 81 | 26% |
Clofarabine and nelarabine: two new purine nucleoside analogs | 2006 | 20 | 50 | 84% |
Three new drugs for acute lymphoblastic leukemia: Nelarabine, clofarabine, and forodesine | 2007 | 10 | 31 | 90% |
Nelarabine: A novel purine antimetabolite antineoplastic agent | 2007 | 10 | 17 | 76% |
The role of clofarabine in hematologic and solid mal ignancies - Development of a next-generation nucleoside analog | 2005 | 54 | 38 | 45% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CANC THER EUT IMMUNOL | 18 | 89% | 3.3% | 8 |
2 | BLOOD BONE MARROW TRANSPLANTAT PROGRAM | 1 | 33% | 0.8% | 2 |
3 | GARRON FAMILY CANC | 1 | 50% | 0.4% | 1 |
4 | CLIN VIROL F68 | 0 | 14% | 1.2% | 3 |
5 | LEUKEMIA CLIN | 0 | 33% | 0.4% | 1 |
6 | LEUKEMIA EXPT THER EUT | 0 | 33% | 0.4% | 1 |
7 | LUND STRATEG STEM CELL BIOL THER Y | 0 | 33% | 0.4% | 1 |
8 | MD ANDERSON CANCER CLIN INVEST | 0 | 33% | 0.4% | 1 |
9 | ONCOL HEMATOL CHEMOTHER Y | 0 | 33% | 0.4% | 1 |
10 | ONCOL HEMATOL PEDIAT TRANSPLANTOL | 0 | 33% | 0.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000248937 | FLUDARABINE//CHRONIC LYMPHOCYTIC LEUKEMIA//CLADRIBINE |
2 | 0.0000216697 | POLG//MNGIE//DEOXYRIBONUCLEOSIDE KINASE |
3 | 0.0000205253 | GEMCITABINE//TROXACITABINE//DEOXYCYTIDINE KINASE |
4 | 0.0000199547 | URACIL ARABINOSIDE//ARA CTP//CYTOSINE ARABINOSIDE |
5 | 0.0000158349 | ACUTE MYELOID LEUKEMIA//GEMTUZUMAB OZOGAMICIN//AML |
6 | 0.0000146609 | PURINE NUCLEOSIDE PHOSPHORYLASE//NUCLEOSIDE PHOSPHORYLASES//CARBOHYDRATE CHEM TEAM |
7 | 0.0000131300 | ACUTE LYMPHOBLASTIC LEUKEMIA//MINIMAL RESIDUAL DISEASE//ACUTE LYMPHOBLASTIC LEUKAEMIA |
8 | 0.0000082204 | PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY//ADENOSINE DEAMINASE//CECR1 |
9 | 0.0000072136 | BUSULFAN//TREOSULFAN//INTRAVENOUS BUSULFAN |
10 | 0.0000068308 | NUCLEOSIDE TRANSPORT//NITROBENZYLTHIOINOSINE//NUCLEOSIDE TRANSPORTER |